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ABSTRACT
Objective: Cancer remains to be one of the leading causes of death around the world. Modern targeted therapies have undeniably improved cancer 
patients’ survival, but search still continues for safer and more effective drugs. This work is an attempt to assess the effectiveness of cotreatment of 
aqueous fruit extract of Morinda citrifolia L. (Noni) on methotrexate (MTX)-induced cytotoxicity on HeLa cancer cell line.
Methods: HeLa cells were treated with different concentrations of MTX and Noni alone and in combination for 24 and 48 h and studied for the 
cytotoxic effects by various approaches.
Results: There was a dose-dependent inhibition of growth when treated with MTX in a dose range of 0.045–45.4 µg/ml and Noni for a dose range of 
0.3–30 mg/ml for 48 h. The IC50 for MTX was 4.45 µg/ml (1 µM/ml), and for Noni, it was 8 mg/ml while the combination exhibited a more intensive 
growth inhibitory effect. Our results were confirmed with phase-contrast microscopy, whereby the number of viable cells decreased with an increase 
in the concentration of Noni. Cells were found to have rounded up and detached from the flask indicating apoptosis. Apoptosis in HeLa cell lines was 
further confirmed by DNA fragmentation and flow cytometry.
Conclusion: It can be concluded that Noni may enhance MTX cytotoxicity by inducing apoptosis and cell cycle arrest. Hence, cotreatment with Noni 
may reduce the dosage of MTX necessary for inhibiting proliferation of malignant cells and hence decrease the toxic effects of MTX on the system.
Keywords: Morinda citrifolia L., Methotrexate, HeLa cell lines, DNA fragmentation, Flow cytometry, Apoptosis.
INTRODUCTION
Many nutraceuticals and plant active compounds are an important 
historical and ethnobotanical source for developing drugs with 
broad-spectrum pharmacological activities such as anticancer, 
antitumor, and antioxidant. An increasing incidence of cancer in 
developing and developed countries has promoted research toward 
dietary and medicinal plant extracts as supplements and prophylactics 
essentially due to the presence of phenolic acids, flavonoids, and 
phenolic diterpenes [1]. Chemotherapy and radiation on human cells 
continuously lead to the generation of reactive oxygen radicals, causing 
noxious effects due to potentially heavy loads of oxidants. Usage of 
alternative medicine is a necessity of the hour as they can be protective 
and can possess antioxidant and antitumor agents which can be more 
effective and reduce toxicity due to the presence of phytochemicals [2,3]. 
In the present study, we have used methotrexate (MTX) which is an 
antineoplastic drug widely used in the treatment of several diseases 
such as autoimmune diseases, lymphoma, and lymphoblastic leukemia 
but has been associated with mild-to-severe liver and intestinal 
toxicity. Aqueous fruit extract from Morinda citrifolia L. (Noni), which 
has a diverse array of active phytoconstituents with multitude of 
pharmacological activities, has been used for cotreatment in our 
study. Noni is used as an herbal remedy and has promising antioxidant 
properties [4].
Currently, there is a growing interest to understand and analyze the 
herb–drug interactions. Most of the oncologists do not recommend 
herbal medicines since it can interact with chemotherapeutic 
drug decreasing the therapeutic benefits. Rather, antioxidants are 
compounds which can act as radical scavengers if present in food 
products and avoid radical chain reaction, delay oxidation, and increase 
the life of cells by retarding lipid peroxidation [5]. Attractive approaches 
to prevent toxicity of different organs should involve the use of natural 
antioxidants. In this study, we introduce a combination of Noni with 
MTX to study anticancer effects against cervical cancer cell line, HeLa.
METHODS
HeLa cell lines P89 were obtained from the National Center for Cell 
Science, Pune. Fetal bovine serum was purchased from Pan Biotech, and 
Penicillin-Streptomycin antibiotic solution, sodium pyruvate solution, 
Dulbecco’s Modified Eagle Medium (DMEM), and Dulbecco’s phosphate-
buffered saline (PBS ×10) were obtained from Mu Lifesciences, Mumbai, 
India.
Folitrax 15 mg/ml of MTX injection was used, and MTX stock was filter 
sterilized and used in different concentrations ranging from 0.045 μg/
ml to 45.4 μg/ml for the assays.
 Noni extract was diluted in DMEM and filter sterilized. Concentrations 
ranging from 0.3 mg/ml to 30 mg/ml were used for the assays.
MTT-based cytotoxicity assay
Cytotoxicity assay was performed as described by Mosmann (1983) [6]. 
Cells were trypsinized and 2500 cells/200 μl were seeded per well of 96-
well plate. Experiments were prepared in triplicates, and the cells were 
incubated at 37°C in CO2 incubator. After 16 h, the medium from the 
well was replaced with medium containing different concentrations of 
M. citrifolia L. fruit extract (0.3–30 mg/ml). Separate wells were treated 
with varying concentration of MTX (0.045–45.4 μg/ml) and with IC50 
of MTX in combination with varying concentrations of M. citrifolia L. 
fruit extract. Control and negative control were also maintained. After 
48 h of incubation with drug, 20 μl of MTT stock solution was added 
per well and incubated for 4 h at 37° for formazan crystal formation. 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i4.31290
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The supernatant was carefully discarded taking care of not losing 
the formazan crystals. The crystals were dissolved by adding 100 μl 
of DMSO, and absorbance was read on a Bio Rad microplate reader 
(version 680) at 570 nm with a reference wavelength of 655 nm. 
The experiment was repeated 3 independent times in triplicates and 
percentage of inhibition was calculated.
Phase-contrast microscopy
Approximately 1×104 cells were seeded in a 24 multi-well plate for 
phase-contrast microscopy. After 24 h, the medium was discarded 
and cells were supplemented with fresh medium. Cells were treated 
with MTX at a final concentration of 0.045–45.4 μg/ml alone, 
0.3–30 mg/ml of M. citrifolia L. fruit extract, and in combination along 
with IC50 (4.54 µg/ml) of MTX with varying concentrations of M. citrifolia 
L. fruit extract for 48 h. A separate well of control was also maintained. 
Phase-contrast microscopy study of treated and non-treated cells was 
performed using Inverted Microscope Nikon ECLIPSE TS100.
DNA laddering assay
DNA was extracted by the method of Gong et al. (1994) [7].
HeLa cells (2×105) were seeded for DNA laddering assay in culture 
plates. After 24 h, the medium was discarded and cells were washed 
with ×1 PBS (pH 7.4) and fresh DMEM medium was added. Cells 
were treated with final concentration IC50 (4.54 µg/ml) of MTX of 
alone, IC50 (8 mg/ml) of Noni alone, and in combination with IC50 of 
Noni and MTX. A separate control was also maintained. After 48 h 
incubation, the supernatant was collected and adhered cells were 
harvested by trypsin treatment.
Electrophoresis was carried out at 60 V until the loading dye migrated 
about three-fourth of the gel. DNA molecular marker of 500–1000 bp 
was run alongside the samples. The DNA was visualized by observing 
the gel using gel documentation system (Syngene).
Clonogenic assay
Clonogenic assay was performed as per the method of Buch et al. 
(2012) [8].
Clonogenic assay was performed on exponentially growing cells. A total 
of 500 cells were seeded in 6 multi-well plates in 1 ml of complete DMEM 
medium and allowed to adhere overnight. After 16 h, the medium was 
removed and replaced with medium containing IC50 (4.54 µg/ml) of 
MTX alone, IC50 (8 mg/ml) of Noni alone, and in combination with IC50 
of Noni and MTX. A separate control was also maintained. After 48 h, 
cells were fed with fresh DMEM medium. After 9 days of treatment, 
media were carefully removed and then washed with PBS. Cells were 
then fixed with methanol: acetic acid (3:1) and stained using 0.5% 
crystal violet in methanol for 15 min. Cells were washed again with 
PBS and colonies were observed. Treated and non-treated cells were 
photographed and each experiment was repeated in triplicate.
Flow cytometry-based apoptosis detection
Flow cytometry analysis of apoptotic cells was done as per the method 
of Riccardi and Nicoletti (2006), Balakrishnan and Bhat (2014), and 
Da’i et al. (2017) [9-11]. Approximately 1×105 cells were seeded in 
multiple 6-well plate for flow cytometry and apoptosis detection. After 
16 h, the medium was discarded and cells were supplemented with 
fresh medium containing IC50 (4.54 µg/ml) of MTX alone, IC50 (8 mg/ml) 
of Noni alone, and in combination with IC50 of Noni and MTX. A separate 
control was also maintained. After 24 h of treatment, the supernatant 
was collected and adhered cells were harvested by trypsin treatment in 
a tube for each concentration-treated cells. The tubes were centrifuged 
at 2500 rpm for 10 min to obtain a cell pellet. The supernatant was 
discarded and cell pellet was washed with 1 ml of PBS (pH 7.4).
The cells were then fixed by adding pre-chilled 2 ml of 70% ethanol 
dropwise to the pellet. The cells at this stage were stored for a week at 
−4°C and then processed for analysis. During analysis, cells were first 
centrifuged at 2500 rpm for 10 min. Ethanol was discarded and cells 
were washed with PBS (pH 7.4) to remove ethanol completely. 500 μl 
of PBS was again added to the cell pellet, and the cells were passed 
gently through 26-gauge needle 3–4 times. 50 μl of RNase A and 5 μl 
of Triton X- 100 were then added to the microfuge tube and incubated 
at 37°C for 30 min. 12.5 μl of propidium iodide was added per tube 
at a concentration of 1 mg/ml and incubated in the dark at 37°C for 
20 min. The DNA content of the cells was analyzed on BD Accuri Flow 
Cytometer. C6 analysis software program was used for acquisition and 
percentage of cells undergoing apoptosis.
Statistical analysis of data
Data are presented as mean ± standard deviation. The statistical 
significance was assessed using one-way analysis of variance followed 
by Student’s t-test. In figures and tables, symbols represent statistical 
significance as indicated: *p<0.05, **p<0.01, ***p<0.001 and NS: Non-
significant.
RESULTS
Cytotoxicity of Noni and MTX
Cytotoxic effect of MTX and Noni alone and in combination on HeLa cell 
lines was checked first with an exposure time of 24 h, but, since it did not 
show any significant effect on the HeLa cells, then it was increased to 48 h.
Fig. 1 shows enhanced cytotoxic effect with increasing concentration 
of MTX from 0.045 µg/ml to 45.4 µg/ml for 48 h. A low dose of MTX 
(0.0454 µg/ml) showed inhibition of cell growth at around 10%, IC50 
Fig. 1: Cell viability of HeLa cells with different concentrations 
of methotrexate by MTT assay. Data represent cell viability with 
different concentrations of MTX after 48 h with mean ± standard 
deviation value from three independent determinations in 
triplicates
Fig. 2: Cell viability on HeLa cells with different concentrations 
of Noni by MTT assay. Data represent cell viability with different 
concentrations of Noni after 48 h with mean±standard deviation 
value from three independent determinations in triplicates
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Fig. 3: Cell viability of HeLa cells with different concentrations 
of Noni and IC50 value of methotrexate (MTX) in combination 
with MTT assay. Data represent cell viability with different 
concentrations of Noni in the presence of IC50 value of MTX 
after 48 h with mean±standard deviation value from three 
independent determinations in triplicates
value was found to be at of 4.45 µg/ml (1 µM/ml), and 100% cytotoxicity 
of MTX was observed at 22.7 µg/ml for 48 h.
Fig. 2 shows the  cell viability results of Noni in a dose range of 
0.3–30 mg/ml, used for standardization. IC50 value for Noni was found 
to be 8 mg/ml.
Fig. 3 shows the results of the combination of Noni in varying concentrations 
with MTX IC50 value of 4.45 µg/ml. Noni was found to inhibit the viability of 
cells with an increase in concentration along with IC50 value of MTX.
Study of the morphology of HeLa cells after MTX and Noni 
treatment
Morphological alterations in HeLa cell lines treated with MTX alone, 
Noni alone, and combination of Noni and MTX along with control were 
observed under an inverted microscope. Control plates with 75–80% 
confluency appeared to be healthy. Considerable cytotoxicity was 
observed in HeLa cells treated with varying concentration of MTX in 
range of 0.0454–45.4 µg/ml for 48 h. Distinctive apoptotic features 
such as cellular shrinkage, reduction in cell volume, cytoplasmic 
Plate 1: Representative photomicrographs of methotrexate (MTX)-treated HeLa cell’s morphology. Cells exposed to increasing 
concentrations of MTX. (a) None. (b) 0.0454 µg/ml. (c) 0.227 µg/ml. (d) 0.44 µg/ml. (e) 2.27 µg/ml. (f) 4.54 µg/ml. (g) 6.810 µg/ml.  
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constriction and membrane blebbing was also observed (Plate 1e-h). 
With an increase in the concentration of MTX (Plate 1h-k), the number 
of attached viable cells decreased and maximum cells were found to be 
floating.
HeLa cells treated with varying concentrations of Noni from 0.3 mg/ml to 
30 mg/ml also showed concentration-dependent cytotoxicity (Plate 2).
Plate 3 shows HeLa cells treated with a combination of MTX 
IC50 (4.45 µg/ml), and varying concentrations of Noni also show cellular 
shrinkage and reduction in volume (Plate 3 - e, f and g); similarly, 
floating cells are observed in Plate 3g-j also.
Plate 4 shows morphology of HeLa cells treated with control (a), 
8 mg/ml of Noni (b), 4.54 µg/ml MTX treated cells (c), and 8 mg/ml 
Noni + 4.54 µg/ml MTX treated cells (d) showing reduction in cell 
number as compared to that of control.
Effect of MTX and Noni on HeLa cell clonogenic assay
Clonogenic assay measures the ability of the cell to retain its normal 
morphological characteristics, proliferation, and the effectiveness 
of a cytotoxic agent is added to cancer cells [12]. With increase in 
concentration of cytotoxic agent there is loss of reproductive integrity 
and inability to proliferate leading to cell death [13]. 
Fig. 4: Effect of Noni on methotrexate (MTX)-induced DNA 
fragmentation. Alphabets indicate wells loaded with DNA isolated 
from cells after different treatments stained with (a) DNA Ladder 
500-1000 bp, (b) untreated cells, (c) 4.54 µg/ml MTX treated, 
(d) Noni 8 mg/ml+ MTX 4.54 µg/ml treated, (e) Noni 8 mg/ml 
treated. Arrow indicates characteristic ladder pattern observed 
in apoptotic cells seen in lane C
Plate 2: Representative photomicrographs of Morinda citrifolia L. fruit extract-treated HeLa cells, morphology. Cells exposed to increasing 
concentrations of M. citrifolia L. fruit extract. (a) None. (b) 0.3 mg/ml. (c) 1.5 mg/ml. (d) 3 mg/ml. (e) 5 mg/ml. (f) 8 mg/ml. (g) 10 mg/ml. 
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Colony formation ability of HeLa cells when treated with MTX and 
Noni fruit extract was assessed. Our study shows that HeLa cells are 
sensitive to MTX alone, Noni alone, and combination of Noni and MTX 
in comparison to control (Plate 5). Since cells number was less than 50, 
plating efficiency could not be calculated.
As can be observed in Plate 5, cells treated with MTX IC50 value (4.54 µg/ml), 
Noni IC50 value (8 mg/ml), and a combination of 8 mg/ml Noni and 4.54 µg/ml 
MTX showed distinct fragments that ultimately lead to collapse of the cells, 
nuclear disintegration, destabilization of nuclear envelope, and lamin 
proteolysis (Plate 4 - b, c, d). These photographs establish the synergistic 
effect of Noni fruit juice on MTX-induced cytotoxicity.
Effect of Noni and MTX on DNA fragmentation
Apoptosis is a distinctive feature of cell death due to the release of 
nuclear DNA from apoptotic cells. HeLa cell lines treated with MTX and 
Noni were analysed for DNA fragmentation. DNA ladder 500-100bp was 
used for comparison. (Fig. 4a) DNA of cells treated with MTX IC50 (Fig. 4c) 
showed ladder with some smearing. There was no DNA fragmentation 
or smearing of DNA in control (Fig. 4b), but the combination of Noni + 
MTX and Noni alone showed smearing which might be due to necrosis 
of cells (Fig. 4d and e). This also serves as a vital biochemical marker for 
measurement of drug-mediated cytotoxicity.
Plate 4: Representative photomicrograph showing morphology of 
HeLa cells. Cells treated with (a) none. (b) 8 mg/ml of Noni.  
(c) 4.54 µg/ml methotrexate (MTX). (d) 8 mg/ml Noni + 
4.54 µg/ml MTX-treated cells
dc
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Plate 3: Representative photomicrographs of HeLa cells treated with combination of methotrexate (MTX) and Noni. Cells exposed to 
combination of varying concentrations of Noni and 4.540 µg/ml of MTX. (a) None. (b) 1.5 mg/ml of Noni. (c) 3 mg/ml of Noni. (d) 5 mg/ml 
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Cells treated with MTX IC50 4.54 µg/ml, however, showed 25.86%±7.78 
of apoptotic cells and 74.14% viable cells. Fig. 7a and b shows a number 
of cells captured with no gate and gate R2 later. Fig. 7c and d represents 
the sub G1 phases which determine the number of apoptotic cells in the 
IC50 4.54 µg/ml.
Cells treated with Noni and MTX, however, showed 21.13%±2.68 of 
apoptotic cells and 78.87% viable cells. Fig. 8a and b shows a number 
of cells captured with no gate and gate R2 later. Fig. 8c and d represents 
the sub G1 phases which determine the number of apoptotic cells in the 
Noni and MTX.
Our results indicate that cytotoxicity of Noni or MTX by themselves and 
in combination as detected by MTT assay and clonogenic assay showed 
a decrease in survival of cancer cells. As shown in Fig. 9a, combination 
of Noni and MTX can enhance apoptosis as compared to either 
Noni alone (p<0.001) or MTX alone (p<0.001). Fig. 9b is a pictorial 
representation of multiple samples run in gated (P5 in R2). Black peak 
represents control with 89.41% viable cells and 10% apoptotic cells. 
Red peak represents Noni extract-treated cells with 75.20% viable 
cells and 24.8% apoptotic cells. Blue peak represents cells treated 
with Noni +MTX showing 71.83% viable cells and 28.17% apoptotic 
cells; similarly, green peak represents cells treated with MTX showing 
61.36% viable cells and 38.64% apoptotic cells.
Even though the number of apoptotic cells appears to be more in 
pictorial graph (Fig. 9b), Fig. 9a shows a greater number of apoptotic 
cells in Noni and MTX in comparison to that of MTX alone in histogram. 
This could be due to the scatter of cells obtained during acquisition of 
data.
DISCUSSION
Natural plant compounds have attracted attention as alternative 
therapeutics in the fight against diseases, primarily due to their low 
toxicity and high therapeutic index. Plant-derived drugs such as 
vinblastine, vincristine, taxol, and camptothecin are already accepted as 
potent chemotherapeutic agents. Here, we explore the antiproliferative 
potential of fruit extracts of M. citrifolia alone and in combination with 
a well-accepted drug, MTX, by in vitro methods.
Our results for viability assay performed on MTX alone, Noni alone, 
and combination of Noni with MTX-treated cells were found to be 
highly significant. Singh et al. (2013) have also reported that addition of 
varying concentration of Noni alone, cisplatin alone, and combination 
of both reduced the cell survivals, respectively, by 22%, 29%, and 50% 
in HeLa cell lines [15]. The concentration of cisplatin used in their study 
was 10 µg/ml and Noni extract used was 10%, v/v for 24 h.
In our study, we have observed that about 50% of HeLa cells showed 
cytotoxicity even with a concentration of 8 mg/ml of Noni alone and 
MTX 4.54 µg/ml alone, whereas a minimum dose of MTX 4.54 µg/ml 
in combination with Noni (8 mg/ml) is sufficient enough to be 52% 
cytotoxic after 48 h, showing an additive effect and hence proving that 
small amount of chemotherapeutic drug can be used along with Noni as 
a chemoadjuvent to boost the cytotoxic potential.
Noni by itself has a cytotoxic effect on HeLa cell lines. Cells rounded 
up and detached from the plate and their neighbouring cells with 
subsequent condensation of cytoplasm. Dissolution of nuclear envelope 
along with separation of the nucleus into distinct fragments leading to 
collapse of cells into several small intact vesicles were also observed. 
A similar result was seen when we combined the IC50 value of MTX 
with increasing concentration of Noni. Plasma membrane blebbing, 
collapse of cells, number of viable cells decreased with an increase in 
concentration, and retraction were observed in treatment with  IC50 
value of MTX and increasing concentration of Noni.
Our studies indicate that Noni co-treatment with lower dose of MTX 
can induce morphological changes such as, necrosis and cell death 
Flow cytometry to study the effect of Noni on MTX-induced 
apoptosis on cell lines
Cells experience a mode of cellular suicide called apoptosis under 
normal physiological conditions. Cell undergoing apoptosis shows 
morphological characteristic changes such as formation of round 
apoptotic bodies appearing like round spherical beads, nuclear 
condensation, and shrinkage [14].
Flow cytometry and propidium iodide staining was used to investigate 
antiproliferative effect of Noni and chemotherapeutic drug MTX on the 
cell cycle distribution of HeLa cells.
Control cell showed a 6.3%±2.56 of apoptotic cells and 93.7% displayed 
characteristic normal cell cycle distribution. All the analyses were done 
in triplicates.
Fig. 5a and b shows a number of cells captured with no gate and gate 
R2 later. Fig. 5c and d represents the subgenomic cells in sub G1 phase 
peak in red color which determines the number of apoptotic cells in the 
control. Black peak indicates G0–G1 phase.
Cells treated with Noni IC50 8 mg/ml, however, showed 9.4%±3.38 of 
apoptotic cells and 90.60% viable cells.
Fig. 6a and b shows a number of cells captured with no gate and gate R2 
later. Fig. 6c and d represents the sub G1 phases which determine the 
number of apoptotic cells in the Noni IC50 8 mg/ml.
Plate 5: Photomicrograph showing morphology of methotrexate 
(MTX)-treated HeLa cells post-clonogenic assay stained with 
0.5% crystal violet in methanol (×100 and ×200). (a) Growing 
colony of untreated HeLa cells. (b) 8 mg/ml Noni pre-treated 
cells with abnormal morphology. (c) 4.54 µg/ml MTX pre-treated 
cells with abnormal morphology. (d) 8 mg/ml Noni + 4.54 µg/ml 
MTX pre-treated cells with narrower, long strips, stretched out 
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Fig. 5: (a-d) Representative histogram showing quantitative detection of apoptotic population in control HeLa cells by flow cytometry
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proving to be very good cytotoxic agent, equivalent to higher doses of 
MTX alone.
Similar cytotoxicty with extracted chlorophyllin from fresh leaves of 
M. citrifolia L. has been also reported on Hep G2 and Vero cell lines [16], 
which suggest higher safety ratio, indicating potential use in cancer 
treatment as the extract inhibits only the growth of cancer cells but not 
normal cells.
Clonogenic assay is a conventional and more frequently used in vitro 
assay to visually witness cloning efficiency. Chemotherapeutic drug 
leads to remarkable phenotypic changes, [17] and damage to 
chromosomes leading to apoptosis [18]. This assay detects the ability 
of all cells that have retained the capacity for producing a large number 
of progenies after treatment.
The studies on the effect of curcumin-induced apoptosis in human 
mammary carcinoma cells (MDA-MB-23) reported by Latifah et al. 
(2006) are similar to our results, which again emphasize Noni fruit 
juice’s synergistic effect on cytotoxicity induced by MTX [19].
Consistent slow growth rate, inability to form clones, no surviving 
colonies, and only few cells were observed in all the three plates that 
were treated with Noni and MTX. We observed that the cell number in 
MTX alone, Noni alone, and combination of Noni and MTX was less than 
50 as compared to that of control.
Induction of apoptosis in HeLa cell lines was confirmed by DNA 
fragmentation. These degraded DNA produces a ladder pattern which 
is a hallmark of cytotoxicity and drug-induced apoptosis in cancer cells 
as observed  on an agarose gel [20]. Xie et al. (2016) have stated that 
MTX can be lethal to cancer cells, as well as normal cells, and hence, 
the use of a combination of Noni and MTX can be more beneficial in 
the treatment of cancer [21]. Breakdown of cellular DNA caused due to 
activation of endogenous nuclear endonucleases and proteases, cleave 
double-stranded DNA at sites situated on linker DNA leading to DNA 
laddering. The release of these enzymes from cytoplasmic membrane is 
a sign of inhibition of DNA replication.
Treated or damaged cells can be evaluated by cell cycle analysis. Certain 
checkpoints are interrupted due to damage that occurs in the cell during 
cell cycle, hence preventing normal cells from being transformed into 
cancer cells [9].
G1 phase nuclei of apoptotic cells contain less DNA than healthy cells. 
Apoptosis is evaluated by quantification of percentage cells in the 
sub-G1 phase. A sub G0/G1 peak was seen before G1 in a flow cytometry 
histogram. Cycle cell analysis carried out to check the synergistic 
effect of Noni and MTX on HeLa cell lines showed an increment in sub 
G0/G1 population indicating the occurrence of apoptosis which was in 
concurrence to decrement in the percentage of viable cells in MTT and 
clonogenic assays.
Sharma et al. (2016) reported that cell cycle distribution in MCF -7 and 
MDA-MB-231 cell when exposed to Noni ethyl acetate extract at IC50 for 
24, 48, and 72 h showed a noticeable increase in the G1/S phase in a 
time-dependent manner [20]. They have reported 81% apoptotic cells 
which are comparable to our results for the same time duration [22]. Our 
results are also in accordance with Gupta et al. (2013) and Alitheen et al. 
(2016) [2,23]. The latter have used the combination of doxorubicin and 
damnacanthal, and the population of MCF-7 cells decreased more when 
treated in a combination of two rather than individual agents alone.
Combination therapy (Noni and MTX) remarkably increased apoptotic 
index, thereby promising herbal-based anticancer agent. An important 
homeostatic mechanism can be established by induction of apoptosis 
Fig. 7: (a-d) A representative histogram showing quantitative detection of apoptotic population in 4.54 µg/ml of methotrexate-treated 
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which regulates cell division and cell death leading to cytotoxicity that 
can maintain suitable cell number. Noni has been identified for its 
antiproliferative potential against tumor cells. In accordance, if plant 
extracts and their constituents have an ability to inhibit cancer cells 
without disturbing normal cells, they can have an immense potential in 
the treatment of cancer [24,25]. The synergistic combinations of Noni 
with existing anticancer drugs can enhance efficacy, reduce side effects, 
boost immune modulation, as well as abrogate drug resistance.
CONCLUSION
The results of this study show that Noni extract was able to induce 
growth inhibition, apoptosis, and cell cycle arrest alone and in 
Fig. 9: Comparative graph of the percentage of apoptotic cells. (a) Results of flow cytometry analysis showing percentage apoptosis of 
HeLa cells in control and after 4.54 µg/ml of methotrexate (MTX), 8 mg/ml of Noni, and combination of 8 mg/ml of Noni + 4.54 µg/ml of 
MTX treatment. (b) Plot of comparative percentage of apoptotic cell in control, 4.54 µg/ml of MTX, 8 mg/ml of Noni, and combination of 
8 mg/ml of Noni + 4.54 µg/ml of MTX treated in HeLa cells by flow cytometry. Comparisons are expressed as “a” Groups I, II, III, and IV  
“b” Groups II and III, Statistical significance represented as: **p<0.01, ***p< 0.001, NS: Non-significant
ba
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combination with MTX. The combined use of Noni and lower MTX dose 
could potentially reduce the side effects/toxicity of the drug while not 
compromising on its therapeutic potential.
Noni as a chemoadjuvent can be one of the effective methods in reducing 
MTX dose administered to cancer patients during chemotherapy, 
thereby reducing toxicity to normal cells as well as side effects caused 
by chemotherapeutic drugs during the course of treatment.
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